- Press Release -

Rockville, Md. The global bone growth stimulator market is set to grow from more than US$ 1.4 Bn in 2017 to US$ 1.91 Bn by 2022, a 5.3% CAGR that Fact.MR ties to the slow, difficult recovery many spinal fracture patients face. As devices become more comfortable to use, surgeons are steering more of those patients toward stimulation therapy.

Stimulation devices carry most of the revenue, hospitals and clinics account for the bulk of use, and North America leads by region. Platelet-rich plasmas, though smaller, are the fastest-growing product line as clinicians look for options that speed healing.

Products, Applications and Settings

Bone growth stimulation devices hold close to 56% of revenue in 2017 and remain the core of the market. Platelet-rich plasmas are the segment to watch, growing at a 6.2% CAGR and heading past US$ 450 Mn by 2022. By application, delayed and non-union fracture treatment expands at 5.7%, spinal fusion surgeries make up roughly a quarter of sales, and oral and maxillofacial procedures bring in around US$ 250 Mn. Hospitals and clinics are the leading end user, at more than 43% share and over US$ 800 Mn by 2022, while home care opens an incremental opportunity above US$ 100 Mn.

North America stays the largest region and grows at a 6.2% CAGR on high healthcare spending, Europe reaches US$ 600 Mn by 2022, and Asia Pacific excluding Japan passes US$ 225 Mn as spinal fracture incidence rises and local manufacturing expands.

Comfort and Access Drive Uptake

The market's momentum rests on two things: devices that reduce patient discomfort and wider access to care. In emerging markets, higher fracture rates tied to road and infrastructure gaps are pulling demand forward, while low production costs make the region attractive for manufacturing. Together these forces broaden the patient base through the forecast period.

Suppliers and Their Playbook

The field brings together orthopaedic device majors and specialist stimulator makers.

• Orthofix International N.V., Medtronic plc, Zimmer Biomet Holdings, Inc., Bioventus Inc., Stryker Corporation, Johnson & Johnson, Arthrex, Inc., DJO Global Inc., Elizur Corporation, and Ossatec Benelux B.V. are among the leading players profiled in the report.

Reading the Market for Decisions

For device makers, growth favours comfortable stimulation devices and fast-rising platelet-rich plasma lines. Investors get a market with steady clinical demand. Procurement teams can plan around hospitals and clinics leading use, spinal applications carrying volume, and North America offering the largest opportunity through 2022.

About the Report

Fact.MR's study covers the global bone growth stimulator market for the 2017 to 2022 forecast period, with segmentation by product, application, end user and region. It sizes each segment, maps the competitive field, and weighs the clinical forces shaping demand. Further detail is available in the bone growth stimulator market report.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. The firm is known for its syndicated research, custom research and consulting solutions, helping clients make decisions on demand, competition, investment, procurement and future growth.